TargetMol

Iopamidol

Product Code:
 
TAR-T1576
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T1576-25mg25mg£99.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1576-1mL1 mL * 10 mM (in DMSO)£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1576-50mg50mg£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1576-100mg100mg£122.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1576-200mg200mg£148.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1576-500mg500mg£207.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Iopamidol is an organic iodine compound and used as a non-ionic water-soluble radiographic contrast medium.
CAS:
60166-93-0
Formula:
C17H22I3N3O8
Molecular Weight:
777.089
Purity:
0.9947
SMILES:
C[C@H](O)C(=O)Nc1c(I)c(C(=O)NC(CO)CO)c(I)c(C(=O)NC(CO)CO)c1I

References

1. Longo DL, et al. Magn Reson Med. 2011, 65(1):202-11. 2. Doan R, et al. 55th Annual Meeting of the Orthopaedic Research Society. Poster No.2166 3. Dundore RL, et al. Invest Radiol. 1991, 26(8):715-21. 4. Xu S, Wang L, Zhao L. Clinical application value of brain CT perfusion imaging in the treatment of acute ischemic stroke thrombolytic therapy[J]. Experimental and therapeutic medicine. 2019 May;17(5):3971-3976.